US equities
|
NVDA
$241.81
▲+1.22%
SPCX
$173.94
▲+1.67%
MU
$1,065.08
▲+0.11%
AMD
$656.88
▲+3.98%
MRVL
$291.96
▲+7.64%
SNDK
$1,674.45
▼-1.74%
AVGO
$378.65
▲+4.45%
TSLA
$380.23
▲+0.39%
NVDA
$241.81
▲+1.22%
SPCX
$173.94
▲+1.67%
MU
$1,065.08
▲+0.11%
AMD
$656.88
▲+3.98%
MRVL
$291.96
▲+7.64%
SNDK
$1,674.45
▼-1.74%
AVGO
$378.65
▲+4.45%
TSLA
$380.23
▲+0.39%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Regencell Bioscience Holdings Limited
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial
September 12, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
May 18, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
May 16, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
February 16, 2022
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors
December 13, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO
November 22, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index
November 22, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment
September 02, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option
August 20, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders
August 05, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering
July 20, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering
July 15, 2021
From
Regencell Bioscience Holdings Limited
Via
Business Wire
Tickers
RGC
